Yes. Bicalutamide’s absorption is not significantly affected by food, so it can be taken with or without meals. Maintaining a consistent routine, however, helps improve adherence.
Mild skin irritation is common, but a sudden or severe rash may indicate a serious reaction. Discontinue the medication and seek medical attention promptly to evaluate for possible Stevens-Johnson syndrome or other severe dermatologic events.
Casodex is often used together with LHRH analogues (e.g., leuprorelin). Combining it with other anticancer agents should only occur under oncologist supervision, as drug-drug interactions and cumulative toxicity must be monitored.
Liver function tests are essential at baseline and periodically thereafter, especially during the first three months. PSA monitoring is also standard to track disease response.
Bicalutamide is contraindicated in pregnant or breastfeeding women because it can cause fetal harm. Its use in women for off-label indications is rare and should only be considered by a specialist with strict risk assessment.
Surgical castration removes the testes, drastically lowering testosterone. Casodex blocks any remaining androgen activity at the receptor level, allowing patients to retain testicular function while still suppressing cancer growth.
Bicalutamide can impair spermatogenesis and reduce fertility. Men planning to father children should discuss sperm banking with their healthcare provider before initiating therapy.
Older adults often have reduced hepatic clearance. Dose adjustment may be needed for those with moderate liver disease, and careful monitoring for side effects is recommended.
Yes. Keep the medication in its original prescription bottle, carry a copy of the prescription, and declare it if requested. The tablet form poses no security issues.
Casodex is a branded prescription product; costs are typically covered under the NHS for eligible patients. Generic bicalutamide may be available at a lower price, but pricing details vary by pharmacy and patient eligibility.
Casodex is a prescription medication that contains the active ingredient bicalutamide. It belongs to the therapeutic class of androgen receptor antagonists, used as part of oncology support for men with prostate cancer. Casodex is supplied as a 50 mg oral pill. In the United Kingdom, it is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and requires a prescription from a qualified healthcare professional.
Bicalutamide blocks the androgen (testosterone) receptor in prostate cells, preventing the hormone from stimulating cancer growth. By occupying the receptor, the drug inhibits the downstream signaling that normally drives tumor proliferation. The medication is absorbed after oral administration, reaching peak plasma concentrations within 2-4 hours. It has a long half-life of approximately 5-7 days, allowing once-daily dosing. Bicalutamide is metabolised primarily in the liver by the cytochrome P450 enzyme system (mainly CYP3A4) and is eliminated mainly via biliary excretion.
Prostate Cancer - Bicalutamide is approved in the UK for the treatment of locally advanced or metastatic prostate cancer in combination with a luteinising-hormone-releasing hormone (LHRH) analogue or after surgical castration. The combination lowers circulating testosterone while bicalutamide blocks any residual androgen activity at the tumour site.
Typical patient profile: Adult men diagnosed with advanced prostate cancer who are not candidates for or who require additional androgen blockade beyond LHRH therapy.
Evidence from peer-reviewed studies suggests bicalutamide has been explored in:
These uses are not approved by the MHRA. Off-label application must be supervised by a qualified healthcare provider, with careful risk-benefit assessment.
Ideal candidates are men with advanced prostate cancer needing androgen blockade.
Absolute contraindications
Relative contraindications
Special populations
If you fall into any of these categories, a thorough medical evaluation is essential before starting Casodex.
Patients should disclose all prescription medicines, over-the-counter drugs, herbal supplements, and vitamins to their prescriber.
Administration tip: Swallow the tablet whole; crushing or chewing may affect absorption and increase gastrointestinal irritation.
If abnormal labs or symptoms arise, the prescriber may adjust the dose or discontinue therapy.
This article provides educational information about Casodex (bicalutamide) and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
